Local News: Annville, PA 

 | 

Sign Up

 | 

Sign In

Advertisment

GlaxoSmithKline News Editors

RoboBlogger

I edit this news page on Topix when no humans are available to help.

People just like you make GlaxoSmithKline News on Topix better every day. If you're interested in becoming an editor, apply today!

Edits History | Editor Blog

RSS icon mobile icon

GlaxoSmithKline News

News on GlaxoSmithKline continually updated from thousands of sources around the net.

7 hrs ago | CBC News

More H1N1 shots coming: PM

A boy gets his shot of swine flu vaccine at a Vancouver clinic Monday. The federal government is preparing to ship 1.8 million more doses of the H1N1 vaccine to the provinces.

Comment?

Related Topix: H1N1 Influenza / Swine Flu, Health, Medicine, Influenza, Canada, Stephen Harper, Biotech

16 hrs ago | American Chronicle

News and FDA Updates for Gilead

A complete list of all headlines and biomedical stock developments can be found on BioMedReports.Com On 10/30/09, Gilead Sciences, Inc.

Comment?

Related Topix: Healthcare Law, Law, Food and Drug Administration, Biotech, Medicine, Gilead Sciences, Healthcare Industry, Startups, Dendreon, Opinion

Sat Nov 07, 2009

Globe and Mail

Our federal system is what's really diseased

On H1N1, Canada is a jurisdictional mishmash Four-year-old Rowan Watchmaker looks on as her mother is injected with the H1N1 flu vaccine at a clinic in Ottawa.

Comment?

Related Topix: Canada, North America, World News, H1N1 Influenza / Swine Flu, Health, Medicine, Influenza, Epidemic, Natural Disasters, Biotech

Pharmaceutical Processing

GSK and Pfizer Officially Launch ViiV Healthcare

Today, ViiV Healthcare, a new specialist HIV company established by GlaxoSmithKline and Pfizer, was officially launched.

Comment?

Related Topix: HIV/AIDS, Health, Biotech

Scientific American

Could we be on the verge of a new drug to treat lupus?

Systemic lupus is the most common form of the autoimmune disease, lupus , which afflicts about five million people worldwide and causes a slew of symptoms including fever, pain and swelling.

Comment?

Related Topix: Medicine, Lupus, Health, Biotech, Human Genome Sciences, Healthcare Industry, Healthcare Law, Law, Food and Drug Administration

Fri Nov 06, 2009

Freshnews

GlaxoSmithKline and XenoPort Announce Extension of GSK1838262...

GlaxoSmithKline and XenoPort Announce Extension of GSK1838262 FDA Review Date to February 9, 2010 Submitted by admin on 11/6/2009 @ 6:15 PM Companies mentioned in this article: XenoPort, Inc.

Comment?

Related Topix: Startups, XenoPort, Biotech, Food and Drug Administration, Medicine, Healthcare Industry

WebWire

HHS Orders Intravenous Antiviral Flu Medication to Help Patients Hospitalized with 2009 H1N1

The U.S. Department of Health and Human Services today announced contract awards for up to 120,000 treatment courses of intravenous antiviral drugs to help treat hospitalized 2009 H1N1 influenza patients.

Comment?

Related Topix: H1N1 Influenza / Swine Flu, Health, Medicine, Influenza, Biotech, Healthcare Industry, Tamiflu, Oseltamivir (generic), Medication, Relenza, Zanamivir (generic)

MediLexicon

Antigenics Provides Details On GlaxoSmithKline's Pivotal Malaria Vaccine Trial With QS-21 Adjuvant

Antigenics, Inc. today indicated that GlaxoSmithKline's Phase III malaria vaccine clinical trial, containing Antigenics' QS-21 Stimulon adjuvant, has enrolled more than 5,000 children to date and is expected to involve up to 16,000 children.

Comment?

Related Topix: Biotech, Antigenics, Medicine, Healthcare Industry, Malaria, Health

Medical News Today

GlaxoSmithKline, Pfizer Formally Launch Company To Develop New HIV Treatments

Main Category: HIV / AIDS Also Included In: Pharma Industry / Biotech Industry Article Date: 04 Nov 2009 - 6:00 PST "GSK was at the forefront of breakthroughs in HIV and AIDS treatments in the late 1980s and 1990s with anti-virals such as Retrovir, Epivir and Combivir , which slow the effects of the illness.

Comment?

Related Topix: Biotech, Health

Thu Nov 05, 2009

Easton Express-Times

Human Genome reports positive data on lupus drug

Human Genome Sciences and GlaxoSmithKline said Monday their experimental lupus treatment passed another key goal on its path to potentially becoming the first new drug for the disease in decades.

Comment?

Related Topix: Biotech, Medicine, Human Genome Sciences, Healthcare Industry, Lupus, Health

Mississauga

Feds regret GSK monopoly

Vaccine maker. Federal health officials are questioning whether it's in the public's best interest that Mississauga drug maker GlaxoSmithKline has the monopoly on the H1N1 flu vaccine.

Comment?

Related Topix: H1N1 Influenza / Swine Flu, Health, Canada, Biotech, Medicine, Healthcare Industry, Influenza, North America, World News

MediLexicon

Lupus Research Institute: Benlysta(TM) Trial Results In An Historic...

The Lupus Research Institute and its National Coalition of state and local lupus organizations congratulate Human Genome Sciences and GlaxoSmithKline for achieving an historical landmark - the second positive phase 3 clinical trial of Benlysta , the first successfully tested new drug developed specifically for people with systemic lupus.

Comment?

Related Topix: Healthcare Law, Law, Biotech, Medicine, Human Genome Sciences, Healthcare Industry, Health

POZ

GSK and Pfizer Launch HIV-Specific Drug Company

GlaxoSmithKline and Pfizer announced November 3 the launch of ViiV Healthcare, a collaboration between both pharmaceutical companies' HIV drug divisions.

Comment?

Related Topix: HIV/AIDS, Health, Biotech

Wed Nov 04, 2009

Boston Business Journal

Synta books a profit on GSK payment

Synta Pharmaceuticals Corp. booked a profit and revenue increase in the most-recent quarter due to the accelerated receipt of payments from a partnership with GlaxoSmithKline .

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry

Stratford Beacon Herald

Vaccine supplies drying up

After three weeks of getting over 700,000 H1N1 vaccines a week, Ontario this week will only have some 276,300 doses to administer in the fight against the potentially deadly virus.

Comment?

Related Topix: H1N1 Influenza / Swine Flu, Health, Biotech, Medicine, Healthcare Industry, Canada

Aidsmap

GSK and Pfizer launch joint venture, ViiV Healthcare

The pharmaceutical companies GlaxoSmithKline and Pfizer announced today that the joint venture created by the merger of their HIV divisions is called ViiV Healthcare.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, HIV/AIDS, Health

KTLA-TV Los Angeles

New vaccine offers chance for children in Africa, where 1 million die of malaria each year

A mother watched with dread as a nurse inserted a tube in her baby's head. Blood streamed into the anemic 4-month-old who already has malaria, the mosquito-borne disease that kills a million African children every year.

Comment?

Related Topix: Medicine, Malaria, Health, World News, Kenya, Africa, Biotech, Healthcare Industry

Tue Nov 03, 2009

Canada.com

Global Video: Reconsidering a single supplier

Jacob Wong, 4, is comforted by his mother Johanna Wong as he reacts to getting the H1N1 flu vaccination at a clinic at Metro Hall in Toronto, Ontario, Nov.

Comment?

Related Topix: H1N1 Influenza / Swine Flu, Health, North America, Canada, World News, Epidemic, Natural Disasters, Biotech, Medicine, Healthcare Industry

The Chronicle Herald

Adjuvanted H1N1 vaccine production resumes, drug giant says

The company making Canada's H1N1 vaccine has finished producing a special version of the shot for pregnant women and is again focusing its efforts on the vaccine intended for the majority of Canadians, a spokeswoman said Tuesday.

Comment?

Related Topix: North America, Canada, World News, H1N1 Influenza / Swine Flu, Health, Biotech,

Medical News Today

BENLYSTA™ Successful In Second Pivotal Clinical Trial

Main Category: Lupus Also Included In: Clinical Trials / Drug Trials Article Date: 03 Nov 2009 - 0:00 PST Human Genome Sciences and GlaxoSmithKline announced positive results from BLISS-76, the second of two large-scale phase III clinical trials of BENLYSTA for treating systemic lupus .

Comment?

Related Topix: Medicine, Lupus, Health, Healthcare Law, Law, Biotech, Healthcare Industry, Food and Drug Administration

Annville Jobs

Also on Topix